| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/29/2006 | EP0914427B1 Plasmid-based vaccine for treating atherosclerosis |
| 03/29/2006 | EP0852495B1 Pharmaceutical compositions containing hydroximic acid derivatives |
| 03/29/2006 | EP0837677B1 Brominated hexahydroxybiphenyl derivatives |
| 03/29/2006 | EP0793489B1 Use of statin for the treatment of skin disorders |
| 03/29/2006 | EP0751709B2 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases |
| 03/29/2006 | CN1754100A A screening method |
| 03/29/2006 | CN1753996A The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 03/29/2006 | CN1753994A Vaccines |
| 03/29/2006 | CN1753913A Medicinal composition for ophthal use containing acetylated hyaluronic acid |
| 03/29/2006 | CN1753901A Macrolide solvates |
| 03/29/2006 | CN1753900A Inhibitors |
| 03/29/2006 | CN1753897A Fused bicyclic nitrogen-containing heterocycles |
| 03/29/2006 | CN1753896A Novel compounds and uses thereof |
| 03/29/2006 | CN1753895A Spiro-substituted pyrrolopyrimidines |
| 03/29/2006 | CN1753894A Pyrazolopyridine derivates |
| 03/29/2006 | CN1753893A The enantiomer of tenatoprazole and the use thereof in therapy |
| 03/29/2006 | CN1753892A Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as HIV integrase inhibitors |
| 03/29/2006 | CN1753891A Ccr-3 receptor antagonists |
| 03/29/2006 | CN1753890A Benzoazolypiperazine derivatives having MGLUR1- and MGLUR5-antagonistic activity |
| 03/29/2006 | CN1753889A Quinazoline compounds |
| 03/29/2006 | CN1753888A Hydroxymethyl substituted dihydroisoxazole derivatives useful as antibiotic agents |
| 03/29/2006 | CN1753886A Process for producing acid adduct salt of polyacidic base compound |
| 03/29/2006 | CN1753885A Optically active dihydropyridine derivative |
| 03/29/2006 | CN1753884A Opioid receptor antagonists |
| 03/29/2006 | CN1753883A Improved jasmine aromachemicals |
| 03/29/2006 | CN1753882A Ethynyl derivatives serving as factor XA inhibitors |
| 03/29/2006 | CN1753881A 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis. |
| 03/29/2006 | CN1753880A Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals |
| 03/29/2006 | CN1753879A (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexylmethoxy acetic acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis. |
| 03/29/2006 | CN1753877A Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| 03/29/2006 | CN1753876A New pyridazin-3(2h)-one derivatives |
| 03/29/2006 | CN1753875A Growth promotion method |
| 03/29/2006 | CN1753866A Arylcycloalkyl derivatives having branched side chains used as ppar receptor regulator, processes for their preparation and their use as pharmaceuticals |
| 03/29/2006 | CN1753865A Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals |
| 03/29/2006 | CN1753862A Therapeutic agents |
| 03/29/2006 | CN1753861A Novel aminobenzophenone compounds |
| 03/29/2006 | CN1753693A Uses of anti-insulin-like growth factor I receptor antibodies |
| 03/29/2006 | CN1753691A Subcutaneously-administered ganglioside-based vaccine compositions |
| 03/29/2006 | CN1753687A Use of cpg oligonucleotides in the treatment of hepatitis c virus infection |
| 03/29/2006 | CN1753683A Ophthalmic formulation for the prevention and treatment of ocular conditions |
| 03/29/2006 | CN1753681A Formulation for use in the prevention and treatment of carbohydrate induced diseases and conditions |
| 03/29/2006 | CN1753680A Derivatives of prostaglandins for treating abdominal discomfort |
| 03/29/2006 | CN1753679A Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 03/29/2006 | CN1753678A Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients |
| 03/29/2006 | CN1753677A Ocular hypotensive agent |
| 03/29/2006 | CN1753676A Crystalline non-solvated 1-(4-(2-piperidinylethoxy)phenoxy)-2-(4-methanesulfonylphenyl)-6-hydroxynaphthalene hydrochloride |
| 03/29/2006 | CN1753675A Therapeutic formulations for the treatment of beta-amyloid related diseases |
| 03/29/2006 | CN1753674A Use of tenatoprazole for the treatment of gastroesophageal reflux |
| 03/29/2006 | CN1753673A Prodrugs of gaba analogs, compositions and uses thereof |
| 03/29/2006 | CN1753672A 4,5-diarylthiazole derivatives as cb-1 ligands |
| 03/29/2006 | CN1753671A 1,3-substitued cycloalkyl derivatives having acidic, mostly heterocyclic groups; processes for their preparation and their use as pharmaceuticals |
| 03/29/2006 | CN1753670A Novel derivatives of benzimidazole and imidazo-pyridine and their use as medicaments |
| 03/29/2006 | CN1753669A Hypertonia treatment during the acute phase of a cerebrovascular accident |
| 03/29/2006 | CN1753668A 1,5-diaryl-pyrrole-3-carboxamide derivatives and their use as cannabinoid receptor modulators |
| 03/29/2006 | CN1753667A Composition having autonomic nerve modulating activity and method of use thereof |
| 03/29/2006 | CN1753666A Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 03/29/2006 | CN1753665A Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis |
| 03/29/2006 | CN1753664A Skin-whitening composition |
| 03/29/2006 | CN1753663A Treatment of non-painful bladder disorders using alpha2-delta-subunit calcium channel modulators |
| 03/29/2006 | CN1753662A Therapeutic formulations for the treatment of beta-amyloid related diseases |
| 03/29/2006 | CN1753661A Adenosine a1 receptor antagonist for the treatment of cardiac and renal diseases |
| 03/29/2006 | CN1753660A The use of antimuscarinic drugs |
| 03/29/2006 | CN1753657A Manufacturing process for liposomal preparations |
| 03/29/2006 | CN1753656A Bioadhesive liquid composition which is substantially free of water |
| 03/29/2006 | CN1753625A Stimulation of in vivo production of proteins with formulation comprising leucine |
| 03/29/2006 | CN1753618A Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 03/29/2006 | CN1752110A Sargassum polysaccharide, its preparation method and use |
| 03/29/2006 | CN1752095A C27-steroid antitumour medicine |
| 03/29/2006 | CN1752088A Medicinal composition containing timeazoamine ester |
| 03/29/2006 | CN1752085A Aromatic hydrazide kind compound and its use in preparation of immune inhibitor |
| 03/29/2006 | CN1752078A Aibomycin analogue, its preparation method, medicinal composition and use |
| 03/29/2006 | CN1751740A Medicinal composition for treating arthritis |
| 03/29/2006 | CN1751737A Gynecologic vaginal effervescent tablets and its prepn. method |
| 03/29/2006 | CN1751733A Soft capsule of traditional Chinese medicine Angong Niuhuang and its prepn. method |
| 03/29/2006 | CN1751699A Sofflower injection and its prepn. method |
| 03/29/2006 | CN1751693A Application of astragaloside in medicine for treating or preventing insulin resistance |
| 03/29/2006 | CN1751692A Medicine Rb2 used for thrombolysis, anti reperfusion injury, improving microcirculation and repairing injured tissue and its prepn. method |
| 03/29/2006 | CN1751691A Small volume intravenous injection of gastrodine and its prepn. method |
| 03/29/2006 | CN1751690A Compound injection contg. alendronate sodium and vitamin D3 |
| 03/29/2006 | CN1751689A Method for preparing medicine composition contg. aspirin |
| 03/29/2006 | CN1751688A Wikipedia for application of altitude medicine |
| 03/29/2006 | CN1751687A Medicine composition and its application in prepn. of medicine for treating or preventing cardiovascular and cerebrovascular diseases |
| 03/29/2006 | CN1751686A Novel form of asimidazole for treating chronic rhinitis |
| 03/29/2006 | CN1751685A Novel forms of Asimidazole for treating anaphylactic rhinitis |
| 03/29/2006 | CN1751684A Novel form of Asimidazole for treating nasal polyls or its disease |
| 03/29/2006 | CN1751683A Skeleton type slow-releasing tablets contg. lycopodine-A and its derivatives or its salts and preparing process thereof |
| 03/29/2006 | CN1751682A Novel form of Asimidazole for treating adenoids hypertrophia |
| 03/29/2006 | CN1751681A Novel form of Asimidazole for treating chronic nasosinusitis |
| 03/29/2006 | CN1751680A Method for preparing dripping pills of Onidazole |
| 03/29/2006 | CN1751608A Traditional Chinese medicine additive for cigarette, its prepn. method and quality control method |
| 03/29/2006 | CN1248514C Method and an arrangement for connecting and disconnecting communications links |
| 03/29/2006 | CN1247784C Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 03/29/2006 | CN1247775C Attenuated cattle viral diarrhoea virus |
| 03/29/2006 | CN1247610C 23 position heteroatom substituted analogue of tiger's eye rohdea saponin OSW-1 kind saponin and its synthesis method and use |
| 03/29/2006 | CN1247605C Novel galactosylceramide analogs and beta-glucocerebrosidase activators, external skin preparations and method of activating beta-glucocerebrosidase using the analogs |
| 03/29/2006 | CN1247595C Anhydrous crystal of beta-lactam compound and method for producing the same |
| 03/29/2006 | CN1247594C Bicyclic heteroaromatic compounds |
| 03/29/2006 | CN1247593C Thiepino[3,2-b]dihydropyridines and related compositions and methods |
| 03/29/2006 | CN1247591C Indole derivative and its medicine application |
| 03/29/2006 | CN1247590C Process for synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f]quinoline |